Value
7.7/10data confidence 83%| Component | Sub-score |
|---|---|
| P/E | 2.7 |
| P/S | 8.6 |
| Fwd P/E | 8.7 |
| PEG | 9.5 |
| Analyst target | 9.0 |
- ▸Forward P/E: 13.0x
- ▸PEG: 0.59
- ▸Attractively valued
ARLO · Why this verdict
Why Arlo Technologies (ARLO) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score6.2/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
Arlo offers a rare combination of 26% revenue growth and a forward multiple below 14 times, backed by four consecutive earnings beats averaging nearly 25% above consensus and free cash flow exceeding twice reported net income; sole-source suppliers and exclusive Vietnam manufacturing create single-point-of-failure exposure, and 12% short interest keeps sizing modest while a technical recovery plays out.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Management has beaten earnings estimates in each of the past four quarters with an average upside surprise of nearly 25%, indicating a disciplined pattern of under-promising and over-delivering that reduces negative surprise risk going forward. Earnings | EPS continues to beat consensus estimates by at least 10% in each of the next two reported quarters, sustaining the beat cadence. | →Stable |
| CounterRevenue growing at 26% may be compressing margins as spending scales; if costs outrun revenue in subsequent quarters, the beat streak ends and the valuation re-rates lower. | ||
Revenue is growing at 26% year over year while the stock trades at a forward multiple of 13.4 times with a growth-adjusted ratio well below 1.0, leaving roughly 41% headroom to the analyst consensus target and a risk/reward of nearly 6-to-1 in your favor. Valuation breakdown | The gap between the current price and the analyst consensus target narrows by at least half within 12 months as revenue growth sustains above 20%. | →Stable |
| CounterThe inexpensive multiple reflects genuine execution risk from supply-chain concentration and a small market capitalization; any growth stumble would expose the stock to a sharp de-rating without the cushion a larger business would carry. | ||
Free cash flow equals more than twice reported net income, and the balance-sheet health score stands at 8 of 9, indicating that earnings are strongly backed by real cash rather than non-cash accounting gains. Quality breakdown | Free cash flow conversion remains above 150% of net income over the next 12 months, sustaining the quality signal. | →Stable |
| CounterAn unusually high conversion rate can reflect a period of underinvestment; if growth-related capital spending accelerates, cash generation could normalize sharply below current levels. | ||
Sole-source suppliers and exclusive reliance on Vietnam manufacturing are two flagged single-point-of-failure exposures; any disruption to either could halt production without a ready alternative, creating asymmetric downside that the small market capitalization magnifies. Bear case | No supply-chain disruption is disclosed over the next 12 months and revenue growth remains above 15%, showing the concentration has not impaired the business. | →Stable |
| CounterRevenue growing at 26% year over year indicates the supply chain, while concentrated, has operated without disruption; the risk may remain theoretical unless events specific to the supplier or manufacturing location change the operating environment. | ||
MACD is improving and on-balance volume is rising, suggesting buyers are positioning ahead of a potential trend reversal, though the stock remains below its 200-day moving average with a declining slope that has not yet confirmed the recovery. Momentum breakdown | The stock crosses above its 200-day moving average and holds above it for at least three consecutive weeks within 6 months. | →Stable |
| CounterThe 200-day moving average is in a confirmed downtrend at negative 3.3% per 30 days; MACD improvement has preceded failed reversals before, and 12% short interest could cap any rally before the moving average is reclaimed. | ||
Management has beaten earnings estimates in each of the past four quarters with an average upside surprise of nearly 25%, indicating a disciplined pattern of under-promising and over-delivering that reduces negative surprise risk going forward.
→StableEarnings
- Expectation
- EPS continues to beat consensus estimates by at least 10% in each of the next two reported quarters, sustaining the beat cadence.
CounterRevenue growing at 26% may be compressing margins as spending scales; if costs outrun revenue in subsequent quarters, the beat streak ends and the valuation re-rates lower.
Revenue is growing at 26% year over year while the stock trades at a forward multiple of 13.4 times with a growth-adjusted ratio well below 1.0, leaving roughly 41% headroom to the analyst consensus target and a risk/reward of nearly 6-to-1 in your favor.
→StableValuation breakdown
- Expectation
- The gap between the current price and the analyst consensus target narrows by at least half within 12 months as revenue growth sustains above 20%.
CounterThe inexpensive multiple reflects genuine execution risk from supply-chain concentration and a small market capitalization; any growth stumble would expose the stock to a sharp de-rating without the cushion a larger business would carry.
Free cash flow equals more than twice reported net income, and the balance-sheet health score stands at 8 of 9, indicating that earnings are strongly backed by real cash rather than non-cash accounting gains.
→StableQuality breakdown
- Expectation
- Free cash flow conversion remains above 150% of net income over the next 12 months, sustaining the quality signal.
CounterAn unusually high conversion rate can reflect a period of underinvestment; if growth-related capital spending accelerates, cash generation could normalize sharply below current levels.
Sole-source suppliers and exclusive reliance on Vietnam manufacturing are two flagged single-point-of-failure exposures; any disruption to either could halt production without a ready alternative, creating asymmetric downside that the small market capitalization magnifies.
→StableBear case
- Expectation
- No supply-chain disruption is disclosed over the next 12 months and revenue growth remains above 15%, showing the concentration has not impaired the business.
CounterRevenue growing at 26% year over year indicates the supply chain, while concentrated, has operated without disruption; the risk may remain theoretical unless events specific to the supplier or manufacturing location change the operating environment.
MACD is improving and on-balance volume is rising, suggesting buyers are positioning ahead of a potential trend reversal, though the stock remains below its 200-day moving average with a declining slope that has not yet confirmed the recovery.
→StableMomentum breakdown
- Expectation
- The stock crosses above its 200-day moving average and holds above it for at least three consecutive weeks within 6 months.
CounterThe 200-day moving average is in a confirmed downtrend at negative 3.3% per 30 days; MACD improvement has preceded failed reversals before, and 12% short interest could cap any rally before the moving average is reclaimed.
Per-dimension breakdown
Quality
5.7/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 7.8 |
| ROA | 2.1 |
| Gross margin | 5.0 |
| Op margin | 2.4 |
| Net margin | 2.7 |
| Current ratio | 5.6 |
| FCF quality | 10.0 |
| Moat | 6.8 |
| Piotroski F | 8.9 |
- ▸Excellent cash conversion: 208% FCF/NI
- ▸Strong Piotroski F-Score: 8/9
Growth
9.1/10data confidence 33%| Component | Sub-score |
|---|---|
| Rev growth | 9.1 |
- ▸Strong growth: 26% YoY
Momentum
5.0/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 4.5 |
| MACD | 6.2 |
| OBV | 10.0 |
| MA position | 1.0 |
| Volume | 3.1 |
- ▸Volume accumulation (rising OBV)
- ▸Below 200-MA, MA slope -4.0%/30d — confirmed downtrend
Sentiment
6.9/10data confidence 100%| Component | Sub-score |
|---|---|
| LLM sentiment | 6.2 |
| Analyst rating | 5.0 |
| Price target | 9.9 |
- ▸Analyst upside: 72%
Insider
3.4/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 3.0 |
| insider conviction | 2.0 |
| holder change | 5.1 |
- ▸Notable insider selling — $1,749,972 (0.126% of mkt cap)
Peer rank
5.4/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 4.0 |
| quality rank | 4.4 |
| growth rank | 8.4 |
- ▸Industry growth leader
Technical
6.6/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 9.0 |
| support resistance | 8.4 |
| 52w position | 2.5 |
Risk (lower is worse)
2.0/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 3.9 |
| days to cover | 3.4 |
| volatility | 1.8 |
| put call | 0.0 |
| implied vol | 0.0 |
| beta | 4.8 |
| debt equity | 0.0 |
- ▸Elevated put/call: 9.62
- ▸High IV: 87%
- ▸Concentration risks: 2 HIGH, 1 MED (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
7.0/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
| news activity | 5.0 |
- ▸Perfect beat streak: 4Q
How the verdict was assembled
Engine trigger
Extreme risk factors.
Engine technical detail
verdict_path:
L1:HARD_BLOCKPassed (8)
- MOMENTUM:5.0>=4.5
- ASYMMETRY:5.8>=1.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:43d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- DEATH_CROSS:HARD_BLOCK
Warning (1)
- MOMENTUM:5.0<5.5 (soft — BUY_NOW allowed but watch)
Reward-to-Risk
5.82
Upside
+49.9%
Downside
8.6%
Sizing output
AVOID
SetupRECOVERY — Death cross but MACD improving, RSI 43
EdgeNO_EDGE — No clear edge identified
SuitabilityAGGRESSIVE — Beta 1.55>1.3, MCap $1.4B<$5B
Investment implication
The L1 gate blocked the positive-verdict path: a hard-floor threshold was breached, so dimensional pillars — including Growth at 9.1 could not lift the engine output above the verdict floor. Failed gate signal: DEATH_CROSS:HARD_BLOCK.
The strongest dimensions are Growth at 9.1, Value at 7.7, and Catalyst at 7.0; the weakest are Risk (lower is worse) at 2.0, Insider at 3.4, and Momentum at 5.0. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of 5.82 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Management has beaten earnings estimates in each of the past four quarters with an average upside surprise of nearly 25%, indicating a disciplined pattern of under-promising and over-delivering that reduces negative surprise risk going forward.
Trip ifEPS surprise falls below 0% for 2 consecutive reported quarters.
- P2Revenue is growing at 26% year over year while the stock trades at a forward multiple of 13.4 times with a growth-adjusted ratio well below 1.0, leaving roughly 41% headroom to the analyst consensus target and a risk/reward of nearly 6-to-1 in your favor.
Trip ifRevenue growth falls below 10% YoY for 2 consecutive quarters.
- P3Free cash flow equals more than twice reported net income, and the balance-sheet health score stands at 8 of 9, indicating that earnings are strongly backed by real cash rather than non-cash accounting gains.
Trip ifFree cash flow conversion drops below 100% of net income for 2 consecutive quarters.
- P4Sole-source suppliers and exclusive reliance on Vietnam manufacturing are two flagged single-point-of-failure exposures; any disruption to either could halt production without a ready alternative, creating asymmetric downside that the small market capitalization magnifies.
Trip ifRevenue growth stays above 15% YoY for 4 consecutive quarters, demonstrating supply-chain concentration has not disrupted the business.
- P5MACD is improving and on-balance volume is rising, suggesting buyers are positioning ahead of a potential trend reversal, though the stock remains below its 200-day moving average with a declining slope that has not yet confirmed the recovery.
Trip ifPrice falls more than 15% below the 200-day moving average for 3 consecutive weeks.